Dr. Machiels on Challenges and Ongoing Trials in Head and Neck Cancer

Jean-Pascal Machiels, MD
Published: Monday, Jun 26, 2017



Jean-Pascal Machiels, MD, head of the Department of Medical Oncology, Cliniques Universitaires Sain-Luc, discusses challenges still facing the field of head and neck cancer and ongoing trials with a goal to improve patient outcomes.

There are still many challenges facing the field of head and neck cancer, explains Machiels. Head and neck cancer is mostly induced by tobacco and alcohol use, which adds many comorbidities for these patients.

There are ongoing trials with avelumab (Bavencio) combined with chemoradiation, which can possibly help improve the outcomes for these patients.
 


Jean-Pascal Machiels, MD, head of the Department of Medical Oncology, Cliniques Universitaires Sain-Luc, discusses challenges still facing the field of head and neck cancer and ongoing trials with a goal to improve patient outcomes.

There are still many challenges facing the field of head and neck cancer, explains Machiels. Head and neck cancer is mostly induced by tobacco and alcohol use, which adds many comorbidities for these patients.

There are ongoing trials with avelumab (Bavencio) combined with chemoradiation, which can possibly help improve the outcomes for these patients.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x